Can We Discharge TAVR Patients the Same Day?

For over a decade, TAVR has been showing great benefits, but conduction abnormalities such as RBBB and prior A-V block, continue to be one of the biggest challenges, since in different series the need for definite pacemaker implantation (PPM) varies between 17 to 30% in the large, randomized studies of self-expanding valves.  

alta en el mismo día post TAVI

Even though we are well aware a higher implantation depth of the percutaneous valve (cusp overlapping) has been shown to significantly reduce the need for PPM, it has not yet been tested in large, randomized studies. 

68,482 patients receiving TAVR via femoral approach were looked at. 20,261 (29.6%) of these patients got early discharge (ED), between 0 and 1 day, and 48,221 late discharge (LD), ≥2 days.

Primary end point was rehospitalization for PPM. 

ED patients were younger (79 ± 8 years vs. 80 ± 7.6 years p < 0.01), there were more men, fewer were diabetic or presented kidney failure, COPD, peripheral vascular disease, or stroke, and had more programmed procedures. Besides, they presented fewer conduction abnormalities such as first and second-degree AV block, RBBB and fascicular blocks. 

Read also: Heparin Pretreatment in STEACS Treatment: A New Old Ally?

There were no differences in primary end point between ED and LD patients (2.0% vs. 1.8%; adjusted odds ratio: 1.15; 95% confidence interval: 0.95–1.39; p=0.15). Neither were there differences in readmissions for PPM at 30 and 60 days, or between elective and non-elective readmission. 

Mean time for readmission was 5 days, with no differences between ED and LD.

ED was associated to lower hospital expenses compared against LD.

Read also: RIPCORD 2 Study: Routine Assessment Using Pressure Wires in Acute Coronary Syndrome.

Predictors of PPM were 2-degree A-V block, fascicular blocks, RBBB and kidney failure. 

Conclusion

Early and late discharge TAVR patients who did not require permanent pacemaker implantation during hospitalization showed similar readmission rate for pacemaker implantation. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation. 

Reference: Ahmed M. Elzanaty, et al. Catheter Cardiovasc Interv. 2022;100:245–253.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...